Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Stryker Completes Sixth Deal of 2024
Stryker has made its sixth deal announcement of the year with the completion of its acquisition of NICO Corporation in Indianapolis, Indiana. This acquisition further strengthens Stryker’s commitment to neurotechnology through tumor and stroke care. Financial terms of the deal were not disclosed. NICO Corporation is a privately held company that provides a systematic approach to minimally invasive surgery for tumors and intracerebral hemorrhage procedures. Stryker develops, manufactures and markets specialty surgical and medical products. These include orthopedic implants, powered surgical instruments, endoscopic systems and patient care and handling equipment. Stryker impacts more... Read More »
Cardinal Health to Acquire Integrated Oncology Network for More Than $1.1 Billion
On September 20, Cardinal Health announced that it entered into a definitive agreement to acquire Nashville, Tennessee-based Integrated Oncology Network (ION) for more than $1.1 billion in cash. ION is a physician-led independent community oncology network that partners directly with physicians, hospitals and other healthcare providers to offer the latest services and technologies to patients. Founded in 2008, ION has grown to more than 50 centers nationwide, providing a complete and integrated continuum of care including diagnostic testing, radiation oncology, medical oncology, urology and other ancillary services. Cardinal Health is an American multinational healthcare services company,... Read More »
Flourish Research Receives Strategic Majority Investment from Genstar Capital
Flourish Research has announced a strategic majority investment from San Francisco, California-based Genstar Capital. Based in New York City, Flourish Research is a fully integrated clinical trial organization in North America. The company has sites throughout Alabama, California, Florida, Illinois, North Carolina, Pennsylvania and Texas. Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research. Flourish Research was formed in 2021 by New York-based private equity firm NMS Capital. Genstar Capital is a private equity investment firm that makes leveraged investments in middle-market companies. Genstar has approximately $49... Read More »
RxLive Becomes Wholly Owned Subsidiary of Competitor Scriptology
Tech-enabled medication management company Scriptology announced that it has acquired its competitor, RxLive. RxLive is a concierge telehealth pharmacy service that connects patients with expert pharmacists in a secure, private and personal way. RxLive began in 2017, and over the last seven years, it has made significant investments to build out its technology platform, artificial intelligence and analytics. RxLive sells its medication management platform to other healthcare organizations. Scriptology is an Atlanta, Georgia-based provider of medication management services intended for improving patient outcomes and lowering the total cost of care. Scriptology is a pre-series A... Read More »
SubjectWell Buys Digital Patient Recruitment Provider Trials24
SubjectWell has announced its acquisition of Trials24, a provider of global digital patient recruitment solutions. This marks SubjectWell’s first acquisition announcement since it was acquired by New York-based private equity firm WindRose Health Investors in April 2024. Trials24 is a patient recruitment provider that assists biopharmaceutical companies and contract research organizations in completing clinical trials on time. It offers cutting-edge technology, digital marketing expertise, and an engagement center with local native-language representatives in more than 13 European countries. SubjectWell is a patient access marketplace that connects patients with chronic health conditions... Read More »
Cardiology M&A Activity Cools Off in 2024
Contrary to last year’s industry predictions, the cardiology space within the Physician Medical Group (PMG) sector has not seen a high deal volume and most likely will not exceed the volume of prior years. Between January 1, 2024, and September 13, 2024, there have been 10 cardiology transactions reported. Compared to the same time frame of 2023, where 24 cardiology acquisitions were announced, 2024 is on a downward trajectory. Cardiology accounts for less than 3% of the 357 PMG transactions announced through September 13, 2024. Yet, while this decline may seem concerning, cardiology’s M&A volume for 2024 mirrors historical trends, with the high volume in 2023 (30 deals in... Read More »Espire Dental Acquires Los Gatos Dentistry
Espire Dental, backed by Denver, Colorado-based private equity firm Rallyday Partners, announced that it was expanding its services in California with the acquisition of Los Gatos Dentistry. Los Gatos Dentistry is a dental practice with one location in Los Gastos, California. According to the website, the practice has two providers on staff. Founded in 2018 and headquartered in Denver, Espire Dental is an dental service organization with 27 practices located in Colorado, California, Oklahoma and Wyoming. It seeks and acquires practices with a clinical philosophy that focuses on the patient experience. TUSK Practice Sales advised Los Gatos Dental in connection... Read More »
Northwest Urgent Care to Acquire 10 Carbon Health Urgent Care Centers in Arizona
Northwest Urgent Care, LLC, a Tucson, Arizona-based subsidiary of Community Health Systems, Inc., has signed an agreement to acquire 10 Arizona urgent care centers. The urgent care centers are being acquired from Carbon Health, an American chain of primary healthcare and urgent care clinics that also provides telemedicine. Northwest Urgent Care is part of Northwest Healthcare, an integrated network serving Tucson and nearby communities. Northwest Healthcare offers a full range of services, from specialized cardiac and surgical care to routine primary care, ensuring accessible, high-quality healthcare. The acquisition will expand capacity and increase Northwest Healthcare’s network to more... Read More »
PharmaLegacy Acquires Preclinical CRO BTS Research
PharmaLegacy Laboratories announced on September 16 that it acquired BTS Research, a San Diego, California-based contract research organization (CRO). BTS Research (formerly BioTox Sciences) delivers GLP and Non-GLP biological services to clients in pharmaceutical, biopharmaceutical, biotech, academic research, medical device and related industries. The CRO was founded in 2007 and acquired Bio-Quant in 2011. PharmaLegacy Laboratories is a CRO founded in 2008 which provides efficient and cost-effective preclinical in vitro and in vivo pharmacology studies to life science organizations. PharmaLegacy boasts a thousand of validated in vitro and in vivo services across more than 40 different... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
